Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab

被引：1
|
作者：
Masamoto, Yosuke [1 ]
Taoka, Kazuki [1 ]
Maki, Hiroaki [1 ]
Kurokawa, Mineo [1 ,2 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan
[2] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Tokyo, Japan
来源：
ANNALS OF HEMATOLOGY | 2022年 / 101卷 / 12期
关键词：
Follicular lymphoma; Obinutuzumab; Infusion-related reactions; Risk factors; RITUXIMAB INFUSION; MULTICENTER;
D O I：
10.1007/s00277-022-04987-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2795 / 2797
页数：3
相关论文
共 50 条
  • [31] Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
    Greil, Richard
    Tedeschi, Alessandra
    Moreno, Carol
    Anz, Bertrand
    Larratt, Loree
    Simkovic, Martin
    Gill, Devinder
    Gribben, John G.
    Flinn, Ian W.
    Wang, Zhengyuan
    Cheung, Leo W. K.
    Nguyen, Aaron N.
    Zhou, Cathy
    Styles, Lori
    Demirkan, Fatih
    ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1733 - 1742
  • [32] ASSESSMENT OF BONE MARROW INVOLVEMENT BY FDG-PET/CT IN PATIENTS WITH FOLLICULAR LYMPHOMA
    El-Najjar, I.
    Szyszko, T.
    Mc Dowell, A.
    Matthews, J.
    Gribben, J.
    Montoto, S.
    HAEMATOLOGICA, 2012, 97 : 664 - 664
  • [33] Phenotyping and Visualizing Infusion-Related Reactions for Breast Cancer Patients
    Sun, Deyu
    Sarda, Gopal
    Skube, Steven J.
    Blaes, Anne H.
    Khairat, Saif
    Melton, Genevieve B.
    Zhang, Rui
    MEDINFO 2017: PRECISION HEALTHCARE THROUGH INFORMATICS, 2017, 245 : 599 - 603
  • [34] Agalsidase beta and infusion-related reactions: Findings in Brazilian patients
    Curiati, Marco A.
    Mendes, Carmen Silvia C.
    Aranda, Carolina S.
    Maia, Murilo
    Ensina, Luis Felipe
    Sole, Dirceu
    Martins, Ana Maria
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S37 - S38
  • [35] The role of PET-CT in assessment of bone marrow involvement in patients with follicular lymphoma
    Lerman, Hedva
    Herishanu, Yair
    Joffe, Erel
    Peri, Chava
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [36] Incidence of infusion-related reactions in patients receiving infliximab.
    Buch, MH
    Bryer, D
    Fairclough, A
    ReesEvans, B
    Emery, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S325 - S325
  • [37] Management of infusion-related reactions (IRRs) in patients receiving amivantamab
    Park, K.
    Sabari, J. K.
    Haura, E. B.
    Shu, C. A.
    Spira, A.
    Salgia, R.
    Reckamp, K. L.
    Sanborn, R. E.
    Govindan, R.
    Bauml, J. M.
    Curtin, J. C.
    Xie, J.
    Roshak, A.
    Lorenzini, P.
    Millington, D.
    Thayu, M.
    Knoblauch, R. E.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2021, 32 : S981 - S982
  • [38] Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)
    Smoot, Kyle
    Marginean, Horia
    Gervasi-Follmar, Tiffany
    Chen, Chiayi
    MEDICINA-LITHUANIA, 2024, 60 (04):
  • [39] Bone marrow involvement, in intensively treated patients with intermediate grade non-Hodgkin's lymphoma, is a risk factor for granulocytopenia and fever
    KitayCohen, Y
    Lishner, M
    Shelef, A
    Ravid, M
    Manor, Y
    LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) : 333 - 336
  • [40] Incidence, Risk Factors, and Management of Infusion-Related Reactions in Breast Cancer Patients Receiving Trastuzumab
    Thompson, Lisa M.
    Eckmann, Karen
    Boster, Bonnie L.
    Hess, Kenneth R.
    Michaud, Laura B.
    Esteva, Francisco J.
    Hortobagyi, Gabriel N.
    Barnett, Chad M.
    ONCOLOGIST, 2014, 19 (03): : 228 - 234
12345